The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators

Add time:07/11/2019    Source:sciencedirect.com

The optimization of a series of benzimidazole glucokinase activators is described. We identified a novel and potent achiral benzimidazole derivative as an allosteric GK activator. This activator was designed and synthesized via removal of the chiral center of the lead compound, 6-(N-acylpyrrolidin-2-yl)benzimidazole. The activator exhibited good PK profiles in rats and dogs, and significant hypoglycemic efficacy at 1 mg/kg po dosing in a rat OGTT model. The binding site and binding mode of the benzimidazole class of GKA with GK protein was confirmed by X-ray crystallographic analysis.

We also recommend Trading Suppliers and Manufacturers of N-[5-(acetylamino)-2-methoxyphenyl]-5-bromo-2-(1H-tetrazol-1-yl)benzamide (cas 1040702-80-4). Pls Click Website Link as below: cas 1040702-80-4 suppliers

Prev:Synthesis of N-Substituted phosphoramidic acid esters as “reverse” fosmidomycin analogues
Next:Conformational analysis of 1-chloro-4-iodobutane and 1-chloro-5-iodopentane)